25124676	712	Orbai AM	Anti-C1q antibodies in systemic lupus erythematosus.	Lupus	2015	16
24786080	920	Raj T	Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.	Science	2014	90
15207950	1401	McCarey DW	Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.	Lancet	2004	115
23687260	1401	Yoo DH	A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.	Annals of the rheumatic diseases	2013	57
24168956	1401	Smolen JS	Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial.	Lancet	2014	43
24970784	1401	Dregan A	Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study.	Circulation	2014	25
25367713	1401	Emery P	Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.	Annals of the rheumatic diseases	2015	22
26337719	1493	Bertrand A	Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.	BMC medicine	2015	25
26206882	1956	Uchida J	Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.	Clinical chemistry	2015	25
24226379	2147	De Caterina R	Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.	Thrombosis and haemostasis	2013	28
15668740	2212	Means TK	Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.	The Journal of clinical investigation	2005	174
24696436	2588	Walker MJ	Disease manifestations and pathogenic mechanisms of Group A Streptococcus.	Clinical microbiology reviews	2014	81
9433870	3106	Braun J	Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.	Arthritis and rheumatism	1998	113
22293756	3146	Harris HE	HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.	Nature reviews. Rheumatology	2012	127
20046205	3439	Hall JC	Type I interferons: crucial participants in disease amplification in autoimmunity.	Nature reviews. Rheumatology	2010	57
20519386	3439	Gardner J	Chikungunya virus arthritis in adult wild-type mice.	Journal of virology	2010	94
20177398	3552	Gabay C	IL-1 pathways in inflammation and human diseases.	Nature reviews. Rheumatology	2010	126
26209330	3552	Cavalli G	Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.	Rheumatology	2015	23
26656658	3552	Schett G	Interleukin-1 function and role in rheumatic disease.	Nature reviews. Rheumatology	2016	20
27030597	3553	Masters SL	Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.	Science translational medicine	2016	15
21910626	3569	Tanaka T	Therapeutic targeting of the interleukin-6 receptor.	Annual review of pharmacology and toxicology	2012	56
25648633	3569	Kim GW	IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future.	Archives of pharmacal research	2015	15
15642151	3605	Lubberts E	The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.	Arthritis research and therapy	2005	91
18613831	3605	Tesmer LA	Th17 cells in human disease.	Immunological reviews	2008	186
26699169	3605	Baeten D	Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.	The New England journal of medicine	2015	32
9281381	3630	Jacobson DL	Epidemiology and estimated population burden of selected autoimmune diseases in the United States.	Clinical immunology and immunopathology	1997	226
21843325	4513	Innala L	Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.	Arthritis research and therapy	2011	38
24733962	5657	Burska A	Cytokines as biomarkers in rheumatoid arthritis.	Mediators of inflammation	2014	22
2306288	6293	Wolfe F	The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.	Arthritis and rheumatism	1990	920
12905464	7124	Gómez-Reino JJ	Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.	Arthritis and rheumatism	2003	128
15505111	7124	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Circulation	2004	252
15574639	7124	Newburger JW	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.	Pediatrics	2004	185
16447241	7124	Wolfe F	Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.	Arthritis and rheumatism	2006	60
16705046	7124	Hyrich KL	Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.	Rheumatology	2006	103
17469100	7124	Wolfe F	The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.	Arthritis and rheumatism	2007	57
17632266	7124	Ramos-Casals M	Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.	Medicine	2007	73
18438853	7124	van der Heijde D	Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.	Arthritis and rheumatism	2008	76
19421244	7124	McKellar GE	Role for TNF in atherosclerosis? Lessons from autoimmune disease.	Nature reviews. Cardiology	2009	52
19703304	7124	van der Heijde D	Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.	Arthritis research and therapy	2009	55
22562972	7124	Burmester GR	Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.	Annals of the rheumatic diseases	2013	47
25169849	7124	Sedger LM	TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.	Cytokine and growth factor reviews	2014	40
28264816	7124	Smolen JS	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.	Annals of the rheumatic diseases	2017	12
11407690	10673	Cheema GS	Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.	Arthritis and rheumatism	2001	142
27354687	10673	Lood C	Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.	Rheumatology	2017	5
23242849	26284	Ralph AP	Group a streptococcal diseases and their global burden.	Current topics in microbiology and immunology	2013	45
19188532	51497	Dube SR	Cumulative childhood stress and autoimmune diseases in adults.	Psychosomatic medicine	2009	77
16606649	79841	Avouac J	Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.	Annals of the rheumatic diseases	2006	64
23687262	114548	Mathews RJ	Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.	Annals of the rheumatic diseases	2014	33
25651891	149233	Bowes J	Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.	Nature communications	2015	21
